Preparation with Recombinant Human Thyroid-Stimulating Hormone for Thyroid Remnant Ablation with ¹³¹I Is Associated with Lowered Radiotoxicity

Abstract

The lower radiotoxicity with rhTSH, suggested in dosimetry studies, was confirmed in the present prospective investigation, and this advantage occurred without compromising the efficacy of treatment.